Stablishment of Prevention and Treatment System for Intestinal Dysfunction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1/PHASE2

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-01

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dysfunction and intestinal endocrine dysfunction. This project will use genomics, metabonomics, microbiome and other omics techniques to study the clinical pathway of CID integrated therapy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Validation of Multimodal Digestive Endoscopy

NCT05575765

Colorectal Neoplasms Confocal Laser Endomicroscopy Endoscopy, Digestive System +1 more

SUSPENDED

Gastrointestinal Motility in Patients With Neuroendocrine Tumors

NCT00789841

Neuroendocrine Tumor

COMPLETED

Optical Imaging of Gastrointestinal Biopsy Samples and Their Correlation With Histology

NCT04565704

Gastrointestinal Disease Gastrointestinal Dysfunction

ENROLLING_BY_INVITATION NA

AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases

NCT07087418

Digestive Diseases Radiology AI (Artificial Intelligence) +1 more

RECRUITING

Methodology and Clinical Value of RIT in Intestinal Obstructive Diseases Mediated by Colonic TET

NCT05253222

Fecal Microbiota Transplantation Bowel Obstruction

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bowel Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Intestinal dysfunction is defined as the damage of intestinal substance and/or function, which leads to digestion, absorption and/or mucosal barrier function.

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

living quality

Group Type EXPERIMENTAL

Nutritional Therapy, Metabolic Disorder, Regular

Intervention Type DRUG

According to the result reported by Byrne, Wilmore, etc. in 1992 \~ 1995, the use of growth hormone, glutamine, modified diet and other measures proposed intestinal rehabilitation treatment. Then, check the patient's quality of life survey, nutritional status, inflammation indicators and other changes every three months, and use metabolomics and microbiomic tools to detect changes in the patient's nutritional metabolism, intestinal microecology, etc., and adjust the patient's nutritional treatment and microecological treatment based on the results Program.

complication

Group Type EXPERIMENTAL

Nutritional Therapy, Metabolic Disorder, Regular

Intervention Type DRUG

According to the result reported by Byrne, Wilmore, etc. in 1992 \~ 1995, the use of growth hormone, glutamine, modified diet and other measures proposed intestinal rehabilitation treatment. Then, check the patient's quality of life survey, nutritional status, inflammation indicators and other changes every three months, and use metabolomics and microbiomic tools to detect changes in the patient's nutritional metabolism, intestinal microecology, etc., and adjust the patient's nutritional treatment and microecological treatment based on the results Program.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nutritional Therapy, Metabolic Disorder, Regular

According to the result reported by Byrne, Wilmore, etc. in 1992 \~ 1995, the use of growth hormone, glutamine, modified diet and other measures proposed intestinal rehabilitation treatment. Then, check the patient's quality of life survey, nutritional status, inflammation indicators and other changes every three months, and use metabolomics and microbiomic tools to detect changes in the patient's nutritional metabolism, intestinal microecology, etc., and adjust the patient's nutritional treatment and microecological treatment based on the results Program.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The Patients with chronic bowel dysfunction

Exclusion Criteria

* Past severe underlying diseases of the respiratory system and cardiovascular system,
* Allergy to treatment-related drugs,
* Pregnancy,
* Accept CID surgery.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No